Leading Teams in a Time of Crisis Podcast
The coronavirus (COVID-19) pandemic has changed the nature of work. Leaders must be equipped with the tools necessary to manage teams during moments of crisis and upheaval. The IDSA Leadership Institute is pleased to sponsor a conversation between three ID specialists on how COVID-19 has changed the ways they interact with their teams and how they have modified their leadership behaviors to meet the moment.
This CME activity is intended for infectious diseases and HIV physicians, academicians, pharmacists, and internal medicine physicians.
Participants will be able to:
- Compare and contrast existing leadership models and behaviors in the pre-/post-COVID-19 world
- List strategies for effectively engaging their teams during an emergency
- Recall benchmarks for evaluating their efficacy as communicators
- Summarize approaches for establishing priorities during a crisis
- Recall practices to enhance self-care
Faculty and Disclosures
Moderator: Joshua Hartzell. COI Disclosures: BMJ Best Practices, Honoraria
Panelist: Wendy Armstrong, MD, Professor of medicine. COI Disclosures: Mass Med Soc Journal Watch
Panelist: Constance Benson, MD, Professor of medicine. COI Disclosures: Gilead, Cytodyn, ViiV, GlaxoSmithKline
Planner: Michael Geisler. PharmD. COI Disclosures: nothing to disclose
Staff: Colin Dixon. COI Disclosures: nothing to disclose
Staff: Rachel Shnekendorf, MPH. COI Disclosures: nothing to disclose
The Infectious Diseases Society of America is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Credit Designation Statement
IDSA designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credits commensurate with the extent of their participation in the activity.
- 0.50 AMA PRA Category 1 Credit(s)™